Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RGS16 |
| Upstream (Parents) |
|---|
| (<<) FAP → RGS16 |
| (<<) SULF1 → RGS16 |
| (<<) THY1 → RGS16 |
| (<<) STC1 → RGS16 |
| (<<) COL13A1 → RGS16 |
| (<<) PAM → RGS16 |
| (<<) EGR3 → RGS16 |
| Downstream (Children) |
|---|
| RGS16 → SOX2 (>>) |
| RGS16 → IL11 (>>) |
| RGS16 → PDE6B (>>) |
| RGS16 → PLUNC (>>) |
| RGS16 → KLF9 (>>) |
| RGS16 → POM121L9P (>>) |
| RGS16 → HBZ (>>) |
| RGS16 → SLC4A1 (>>) |
| RGS16 → HDAC7 (>>) |
| RGS16 → EPB42 (>>) |
| RGS16 → FLJ14100 (>>) |
| RGS16 → FAM30A (>>) |
| RGS16 → EGR3 (>>) |
| RGS16 → RPGRIP1 (>>) |
